Aphria (NASDAQ:APHA) Announces Quarterly Earnings Results

Aphria (NASDAQ:APHA) released its quarterly earnings data on Wednesday. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.39), Briefing.com reports. Aphria had a negative return on equity of 2.23% and a negative net margin of 18.30%. The business had revenue of $160.50 million for the quarter, compared to analysts’ expectations of $153.75 million. During the same quarter in the prior year, the firm earned ($0.03) earnings per share. Aphria’s quarterly revenue was up 33.1% compared to the same quarter last year.

APHA traded up $0.29 during trading on Friday, hitting $12.40. The company had a trading volume of 3,703,089 shares, compared to its average volume of 19,269,863. The company has a market cap of $3.70 billion, a PE ratio of -43.90 and a beta of 2.67. Aphria has a 1-year low of $1.95 and a 1-year high of $12.18. The business has a 50-day moving average of $7.54 and a 200-day moving average of $6.41. The company has a debt-to-equity ratio of 0.22, a current ratio of 5.37 and a quick ratio of 3.30.

APHA has been the subject of several research reports. Canaccord Genuity upgraded shares of Aphria from a “hold” rating to a “speculative buy” rating and boosted their price objective for the stock from $11.00 to $17.50 in a research note on Friday. CIBC boosted their target price on shares of Aphria from $12.50 to $18.00 and gave the stock an “outperform” rating in a research report on Friday. Alliance Global Partners boosted their target price on shares of Aphria from $12.00 to $20.00 and gave the stock a “buy” rating in a research report on Friday. Stifel Nicolaus cut shares of Aphria from a “buy” rating to a “hold” rating in a research report on Thursday, December 17th. Finally, Cantor Fitzgerald boosted their target price on shares of Aphria from $11.75 to $26.00 and gave the stock an “overweight” rating in a research report on Friday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $14.23.

About Aphria

Aphria Inc cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands.

Featured Story: Why are analyst ratings important in trading stocks?

Earnings History for Aphria (NASDAQ:APHA)

Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.

Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit